Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.8B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.14B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.12B |
| 4 |
CME Group
CME
|
+$1.06B |
| 5 |
Booking.com
BKNG
|
+$1.05B |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.11B |
| 2 |
Adobe
ADBE
|
+$1.08B |
| 3 |
ServiceNow
NOW
|
+$1.01B |
| 4 |
Intercontinental Exchange
ICE
|
+$994M |
| 5 |
NVIDIA
NVDA
|
+$879M |
Sector Composition
| 1 | Technology | 21.78% |
| 2 | Financials | 10.85% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.91% |
| 5 | Industrials | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Invesco S&P MidCap 400 GARP ETF
GRPM
$452M
| $62.6M | ﹤0.01% |
534,574
+28,290
| +6% | +$3.31M |
|
1627
Bio-Rad Laboratories Class A
BIO
$7.59B
| $62.6M | ﹤0.01% |
186,952
-30,064
| -14% | -$10.1M |
|
1628
Helmerich & Payne
HP
$2.1B
| $62.5M | ﹤0.01% |
2,055,488
+343,566
| +20% | +$10.5M |
|
1629
Capri Holdings
CPRI
$2.43B
| $62.4M | ﹤0.01% |
1,471,465
-697,507
| -32% | -$29.6M |
|
1630
Shinhan Financial Group
SHG
$24B
| $62.4M | ﹤0.01% |
1,472,055
-77,208
| -5% | -$3.27M |
|
|
HQH
1631
abrdn Healthcare Investors
HQH
$898M
| $62.3M | ﹤0.01% |
3,346,167
+174,112
| +5% | +$3.24M |
|
1632
Janus Henderson
JHG
$7.01B
| $62.2M | ﹤0.01% |
1,632,880
+338,807
| +26% | +$12.9M |
|
1633
WisdomTree International Equity Fund
DWM
$603M
| $62M | ﹤0.01% |
1,077,769
+46,060
| +4% | +$2.65M |
|
1634
Nuveen Credit Strategies Income Fund
JQC
$751M
| $62M | ﹤0.01% |
10,712,475
-531,985
| -5% | -$3.08M |
|
|
LINE
1635
Lineage, Inc. Common Stock
LINE
$9.56B
| $62M | ﹤0.01% |
+790,815
| New | +$62M |
|
1636
Flex
FLEX
$21.4B
| $61.9M | ﹤0.01% |
1,852,679
-375,116
| -17% | -$12.5M |
|
1637
Sensata Technologies
ST
$4.55B
| $61.7M | ﹤0.01% |
1,721,267
-1,455,579
| -46% | -$52.2M |
|
1638
Cytokinetics
CYTK
$6.12B
| $61.7M | ﹤0.01% |
1,168,372
+62,698
| +6% | +$3.31M |
|
1639
Stantec
STN
$12.6B
| $61.7M | ﹤0.01% |
766,708
+321,858
| +72% | +$25.9M |
|
1640
Lloyds Banking Group
LYG
$67B
| $61.6M | ﹤0.01% |
19,755,869
+1,368,470
| +7% | +$4.27M |
|
1641
M/I Homes
MHO
$4.07B
| $61.5M | ﹤0.01% |
359,116
+133,614
| +59% | +$22.9M |
|
1642
First Trust US Equity Opportunities ETF
FPX
$1.09B
| $61.5M | ﹤0.01% |
558,313
-10,385
| -2% | -$1.14M |
|
1643
ARK Web x.0 ETF
ARKW
$2.45B
| $61.3M | ﹤0.01% |
719,666
-82,446
| -10% | -$7.02M |
|
1644
United States Oil Fund
USO
$911M
| $61.2M | ﹤0.01% |
875,228
+445,934
| +104% | +$31.2M |
|
|
ITCI
1645
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $61.2M | ﹤0.01% |
836,210
-193,659
| -19% | -$14.2M |
|
1646
BioMarin Pharmaceuticals
BMRN
$10.4B
| $61.2M | ﹤0.01% |
870,224
-326,539
| -27% | -$23M |
|
1647
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $61.1M | ﹤0.01% |
6,068,907
+222,867
| +4% | +$2.24M |
|
1648
Highwoods Properties
HIW
$3.5B
| $61M | ﹤0.01% |
1,819,308
-306,929
| -14% | -$10.3M |
|
1649
Sylvamo
SLVM
$1.75B
| $60.9M | ﹤0.01% |
709,816
+145,341
| +26% | +$12.5M |
|
1650
Coca-Cola Femsa
KOF
$18B
| $60.8M | ﹤0.01% |
685,050
+35,827
| +6% | +$3.18M |
|